The antibiotic resistance problem is triggered by the evolution and transmission of genes that confer resistance to medically essential antibiotics into human pathogens. The acquisition of such resistance genes by pathogens complicates the disease treatment, increases health care costs, and also increases the morbidity and mortality in humans and animals. As antibiotic resistance persists to evolve, antibiotics of so-called last resort developed even more precious. Reducing or avoiding the dissemination of antibiotic resistance genes into human pathogens is presently of high international importance. This session is open to Antibiotic prudency, bacteriophage therapy, predatory bacteria, bacteriocins, and competitive exclusion of pathogens, Immunotherapeutics, Antibodies, Vaccines and gut microbiota modulation.
Related: Antibiotics Conference, Antimicrobial Resistance Congress, Antibiotics Meetings, Antibiotics Event, Drug Resistance Congress, Antibiotic Resistance, Antimicrobial Event, Antibiotics Summit, Antimicrobial Resistance Conference.
Related Conferences: 2nd International Conference on Antimicrobial and Antibacterial Agents on November 11-12, 2019 Istanbul,Turkey; 14th World Congress on Infection Prevention and Control on December 6-7, 2018 at Valencia, Spain; 5th International Conference on Antibiotics & Antibiotic Resistance on May 30-31, 2019 Orlando, Florida,USA.
Related Associations: Alliance for the Prudent Use of Antibiotics, Global Antibiotic Resistance Partnership, Infectious Diseases Society of America, Antibiotic Research UK, The World Alliance Against Antibiotic Resistance, Australian Society of Antimicrobials, Centers for Disease Control and Prevention and Chinese Society for Microbiology.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
